GlycoVaxyn

Company Profile

GlycoVaxyn is a clinical stage biopharmaceutical company focused on the development and manufacture of next-generation glycoconjugate vaccines utilizing its proprietary recombinant DNA technology.

Company Info

  • HQ: Zurich, Switzerland
Founders and CEO:
  • Michael Wacker
Index Team:
Website:
glycovaxyn.com
Sector:
Healthcare
Status:
Current